Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at TRACON Pharmaceuticals Inc fell by 8.86m. However, the company earned 3.68m from its operations for a Cash Flow Margin of 30.52%. In addition the company paid out 12.54m more in cash than they received while cash form investing activities were even.
Cash flow per share | 2.26 |
---|---|
Price/Cash flow per share | 0.1357 |
Book value per share | -0.9065 |
---|---|
Tangible book value per share | -0.9065 |
More ▼
Balance sheet in USDView more
Current ratio | 0.6582 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼